Company Overview
- Website
- cellphire.com
- Phone
- (240) 268-1145(240) 268-1141
- Employees
- 59
- Founded in
- 2005
- Industry
- BioTech/Drugs
- NAICS Codes
-
32 - Manufacturing325 - Chemical Manufacturing3254 - Pharmaceutical and Medicine Manufacturing32541 - Pharmaceutical and Medicine Manufacturing325413 - In-Vitro Diagnostic Substance Manufacturing
- SIC Codes
-
73 - Business Services87 - Engineering, Accounting, Research, Management, and Related Services873 - Research, Development, and Testing Services
Financials & Stats
Revenue
$9B
Total Funding Amount
$20M
Recent News & Media
Contracts For March 31, 2025
- Mar 31, 2025
- defense.gov
Small molecule targeting the Rac1-NOX2 interaction prevents collagen-related peptide and thrombin-induced reactive oxygen species generation and platelet activation
- Nov 22, 2024
- pmc.ncbi.nlm.nih.gov
Cellphire Therapeutics
- Jul 10, 2024
- thepharmaletter.com
Contracts For March 8, 2024
- Mar 7, 2024
- defense.gov
Hemostatic Ability of Thrombosomes® in Blood from Thrombocytopenic Patients Using the Total Thrombus Formation Analysis System (T-TAS) and Confocal Microscopy in Microfluidic Chambers
- Nov 15, 2022
- ashpublications.org
Cellphire Therapeutics Treats First Patient in Phase 2/3 Cryopreserved Platelets Clinical Trial
- Mar 29, 2022
- prnewswire.com
Who is CELLPHIRE INC
Cellphire Therapeutics, Inc. is a biotechnology company headquartered in Rockville, Maryland. The company employs 59 individuals and generates an annual revenue of $9.1 million. Cellphire Therapeutics focuses on developing next-generation therapeutics utilizing its proprietary cell stabilization technology. Their target customer base spans a variety of medical fields, including trauma care, wound care, imaging, targeted drug delivery, and regenerative medicine. The company's lead product, Thrombosomes®, is a freeze-dried hemostatic agent derived from human platelets currently undergoing a Phase I clinical trial. This innovative product has the potential to revolutionize treatments for various medical conditions. For inquiries or further information about Cellphire Therapeutics, please visit their website at cellphire.com.